GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 128,800
-1,700 (-1.30%)
Oct 8, 2026, 10:10 AM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.47 trillion as of October 7, 2026. That makes GC Biopharma the world's 9,722nd most valuable company and 262nd in South Korea. Its market cap has decreased by 2.42% in one year.
Market Cap
1.47T
Enterprise Value
2.45T
Revenue
1.96T
Global Rank
Country Rank
#262 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.47T, an increase of 4,954.06%. That is a compound annual growth rate of 13.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.47T | -18.99% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 2.33T |
| Celltrion Pharm | 1.77T |
| Daewoong Pharmaceutical | 1.27T |
| Chong Kun Dang Pharmaceutical | 872.26B |
| Boryung | 737.79B |
| Daewoong | 659.98B |
| Dong-A Socio Holdings | 637.32B |
| JW Pharmaceutical | 633.47B |